Pacific Biomarkers   Report issue

For profit Phase 3
Founded: Seattle WA United States (1989)

Organization Overview

First Clinical Trial
2009
NCT00982111
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now

Alternative names

Pacific Biomarkers

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Carcinoma, Non-Small-Cell Lung (Phase 3)

Lung Neoplasms (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 4